CZT camera systems may provide better risk stratification for low-risk patients.


Journal

Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
ISSN: 1532-6551
Titre abrégé: J Nucl Cardiol
Pays: United States
ID NLM: 9423534

Informations de publication

Date de publication:
12 2021
Historique:
received: 12 12 2019
accepted: 10 03 2020
pubmed: 6 6 2020
medline: 25 3 2022
entrez: 6 6 2020
Statut: ppublish

Résumé

The photon sensitivity and spatial resolution of single-photon emission-computed tomography (SPECT) has been significantly improved by solid-state camera systems using cadmium zinc telluride (CZT) detectors. While the diagnostic accuracy of these systems is well established, there is little evidence directly comparing the prognostic utility to conventional NaI cameras. Retrospective analysis of patients undergoing SPECT between 2008 and 2012. Visual SPECT assessment was performed utilizing the 17-segment model to determine summed stress scores (SSS). We identified 12,830 consecutive patients, mean age 63.2 ± 13.7 and 56.1% male, 5072 of whom underwent CZT and 7758 NaI imaging. During a median follow-up duration of 7.0 years (IQR 5.5-8.2), a total of 2788 (21.7%) patients died. Compared to SSS 0, minimal perfusion abnormality (SSS 1-3) was associated with increased all-cause mortality with CZT camera (adjusted HR 1.32, P = .017) and NaI camera (adjusted HR 1.29, P = .001, interaction P = .803). Increasing stress abnormality was associated with a similar increase in risk with CZT or NaI imaging (interaction P > .500). In a propensity matched analysis, patients with normal perfusion stress perfusion assessed with a CZT was associated with decreased mortality compared to normal perfusion assessed by a NaI camera system (hazard ratio .88, 95% CI .78-.99, P = .040). Increasing stress perfusion abnormality was associated with similar increase in all-cause mortality with CZT or NaI cameras. CZT and NaI camera systems provide similar risk stratification, however, normal myocardial perfusion may be associated with a more benign prognosis when assessed with a CZT camera system.

Sections du résumé

BACKGROUND
The photon sensitivity and spatial resolution of single-photon emission-computed tomography (SPECT) has been significantly improved by solid-state camera systems using cadmium zinc telluride (CZT) detectors. While the diagnostic accuracy of these systems is well established, there is little evidence directly comparing the prognostic utility to conventional NaI cameras.
METHODS AND RESULTS
Retrospective analysis of patients undergoing SPECT between 2008 and 2012. Visual SPECT assessment was performed utilizing the 17-segment model to determine summed stress scores (SSS). We identified 12,830 consecutive patients, mean age 63.2 ± 13.7 and 56.1% male, 5072 of whom underwent CZT and 7758 NaI imaging. During a median follow-up duration of 7.0 years (IQR 5.5-8.2), a total of 2788 (21.7%) patients died. Compared to SSS 0, minimal perfusion abnormality (SSS 1-3) was associated with increased all-cause mortality with CZT camera (adjusted HR 1.32, P = .017) and NaI camera (adjusted HR 1.29, P = .001, interaction P = .803). Increasing stress abnormality was associated with a similar increase in risk with CZT or NaI imaging (interaction P > .500). In a propensity matched analysis, patients with normal perfusion stress perfusion assessed with a CZT was associated with decreased mortality compared to normal perfusion assessed by a NaI camera system (hazard ratio .88, 95% CI .78-.99, P = .040).
CONCLUSIONS
Increasing stress perfusion abnormality was associated with similar increase in all-cause mortality with CZT or NaI cameras. CZT and NaI camera systems provide similar risk stratification, however, normal myocardial perfusion may be associated with a more benign prognosis when assessed with a CZT camera system.

Identifiants

pubmed: 32500175
doi: 10.1007/s12350-020-02128-x
pii: 10.1007/s12350-020-02128-x
doi:

Substances chimiques

CdZnTe 0
Cadmium 00BH33GNGH
Zinc J41CSQ7QDS
Tellurium NQA0O090ZJ

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2927-2936

Informations de copyright

© 2020. American Society of Nuclear Cardiology.

Références

Fihn SD, Blankenship JC, Alexander KP, Bittl JA, Byrne JG, Fletcher BJ et al. J Am Coll Cardiol 2014;64:1929-49.
doi: 10.1016/j.jacc.2014.07.017
Berman DS, Kang X, Hayes SW, Friedman JD, Cohen I, Abidov A et al. Adenosine myocardial perfusion single-photon emission computed tomography in women compared with men: Impact of diabetes mellitus on incremental prognostic value and effect on patient management. J Am Coll Cardiol 2003;41:1125-33.
doi: 10.1016/S0735-1097(03)00085-8
Hachamovitch R, Rozanski A, Hayes SW, Thomson LE, Germano G, Friedman JD et al. Predicting therapeutic benefit from myocardial revascularization procedures: Are measurements of both resting left ventricular ejection fraction and stress-induced myocardial ischemia necessary? J Nucl Cardiol 2006;13:768-78.
doi: 10.1016/j.nuclcard.2006.08.017
Romero-Farina G, Candell-Riera J, Aguadé-Bruix S, Ferreira-González I, Cuberas-Borrós G, Pizzi N et al. Warranty periods for normal myocardial perfusion stress SPECT. J Nucl Cardiol 2015;22:44-54.
doi: 10.1007/s12350-014-9957-6
Slomka PJ, Patton JA, Berman DS, Germano G. Advances in technical aspects of myocardial perfusion SPECT imaging. J Nucl Cardiol 2009;16:255-76.
doi: 10.1007/s12350-009-9052-6
Garcia EV, Faber TL, Esteves FP. Cardiac dedicated ultrafast SPECT cameras: New designs and clinical implications. J Nucl Med 2011;52:210-17.
doi: 10.2967/jnumed.110.081323
Slomka P, Miller RJ, Hu L-H, Germano G, Berman D. Solid-state detector SPECT myocardial perfusion imaging. J Nucl Med 2019;60 (9):1194-204.
doi: 10.2967/jnumed.118.220657
Bocher M, Blevis IM, Tsukerman L, Shrem Y, Kovalski G, Volokh L. A fast cardiac gamma camera with dynamic SPECT capabilities: Design, system validation and future potential. Eur J Nucl Med Mol Imaging 2010;37:1887-902.
doi: 10.1007/s00259-010-1488-z
Gimelli A, Bottai M, Giorgetti A, Genovesi D, Kusch A, Ripoli A et al. Circ Cardiovasc Imaging 2011;4:51-8.
doi: 10.1161/CIRCIMAGING.110.957399
Duvall WL, Croft LB, Ginsberg ES, Einstein AJ, Guma KA, George T et al. Reduced isotope dose and imaging time with a high-efficiency CZT SPECT camera. J Nucl Cardiol 2011;18:847-57.
doi: 10.1007/s12350-011-9379-7
Sharir T, Ben-Haim S, Merzon K, Prochorov V, Dickman D, Ben-Haim S et al. High-speed myocardial perfusion imaging: Initial clinical comparison with conventional dual detector anger camera imaging. JACC Cardiovasc Imaging 2008;1:156-63.
doi: 10.1016/j.jcmg.2007.12.004
Nkoulou R, Pazhenkottil AP, Kuest SM, Ghadri JR, Wolfrum M, Husmann L et al. Semiconductor detectors allow low-dose-low-dose 1-day SPECT myocardial perfusion imaging. J Nucl Med 2011;52:1204-9.
doi: 10.2967/jnumed.110.085415
Nudi F, Iskandrian AE, Schillaci O, Peruzzi M, Frati G, Biondi-Zoccai G. Diagnostic accuracy of myocardial perfusion imaging with CZT technology. Systemic review and meta-analysis of comparison with invasive coronary angiography. JACC Cardiovasc Imaging 2017;10:787-94.
doi: 10.1016/j.jcmg.2016.10.023
Berman DS, Kiat H, Friedman JD, Wang FP, van Train K, Matzer L et al. Separate acquisition rest thallium-201/stress technetium-99m sestamibi dual-isotope myocardial perfusion single-photon emission computed tomography: A clinical validation study. J Am Coll Cardiol 1993;22:1455-64.
doi: 10.1016/0735-1097(93)90557-H
Berman DS, Abidov A, Kang X, Hayes SW, Friedman JD, Sciammarella MG et al. Prognostic validation of a 17-segment score derived from a 20-segment score for myocardial perfusion spect interpretation. J Nucl Cardiol 2004;11:414-23.
doi: 10.1016/j.nuclcard.2004.03.033
Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the council on clinical cardiology of the American Heart Association. Circulation 2002;105:539-42.
doi: 10.1161/hc0402.102975
Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation 2003;107:2900-7.
doi: 10.1161/01.CIR.0000072790.23090.41
Miller RJH, Hu LH, Gransar H, Betancur J, Eisenberg E, Otaki Y et al. Transient ischaemic dilation and post-stress wall motion abnormality increase risk in patients with less than moderate ischaemia: Analysis of the REFINE SPECT registry. Eur Heart J Cardiovasc Imaging 2019;21:567-75.
doi: 10.1093/ehjci/jez172
Otaki Y, Betancur J, Sharir T, Hu LH, Gransar H, Liang JX et al. 5-Year prognostic value of quantitative versus visual MPI in subtle perfusion defects: Results from REFINE SPECT. JACC Cardiovasc Imaging 2019;13:774-85.
doi: 10.1016/j.jcmg.2019.02.028
Slomka PJ, Berman DS, Germano G. Normal limits for transient ischemic dilation with 99mTc myocardial perfusion SPECT protocols. J Nucl Cardiol 2017;24:1709-11.
doi: 10.1007/s12350-016-0582-4
Joergensen T, Hansson SH. Evaluation of the left ventricular ejection fraction with gated IQ-SPECT myocardial perfusion imaging. J Nucl Med Tech 2015;43:193-200.
doi: 10.2967/jnmt.115.155382
Nakazato R, Berman DS, Gransar H, Hyun M, Miranda-Peats R, Kite FC et al. Prognostic value of quantitative high-speed myocardial perfusion imaging. J Nucl Cardiol 2012;19:1113-23.
doi: 10.1007/s12350-012-9619-5
Engbers EM, Timmer JR, Mouden M, Knollema S, Jager PL, Ottervanger JP. Prognostic value of myocardial perfusion imaging with a cadmium-zinc-telluride SPECT camera in patients suspected of having coronary artery disease. J Nucl Med 2017;58:1459-63.
doi: 10.2967/jnumed.116.188516
Yokota S, Mouden M, Ottervanger JP, Engbers E, Knollema S, Timmer JR et al. Prognostic value of normal stress-only myocardial perfusion imaging: A comparison between conventional and CZT-based SPECT. Eur J Nucl Med Mol Imaging 2016;43:296-301.
doi: 10.1007/s00259-015-3192-5
Elze MC, Gregson J, Baber U, Williamson E, Sartori S, Mehran R et al. Comparison of propensity score methods and covariate adjustment: Evaluation in 4 cardiovascular studies. J Am Coll Cardiol 2017;69:345-57.
doi: 10.1016/j.jacc.2016.10.060
Lima R, Peclat T, Soares T, Ferreira C, Souza AC, Camargo G. Comparison of the prognostic value of myocardial perfusion imaging using a CZT-SPECT camera with a conventional anger camera. J Nucl Cardiol 2017;24:245-51.
doi: 10.1007/s12350-016-0618-9
Abidov A, Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Kang X et al. Are shades of gray prognostically useful in reporting myocardial perfusion single-photon emission computed tomography? Circ Cardiovasc Imaging 2009;2:290-98.
doi: 10.1161/CIRCIMAGING.108.815811
Usher-Smith JA, Sharp SJ, Griffin SJ. The spectrum effect in tests for risk prediction, screening, and diagnosis. BMJ 2016;353:3139.
doi: 10.1136/bmj.i3139
Lauer MS, Blackstone EH, Young JB, Topol EJ. Cause of death in clinical research: Time for a reassessment? J Am Coll Cardiol 1999;34:618-20.
doi: 10.1016/S0735-1097(99)00250-8

Auteurs

Robert J H Miller (RJH)

Departments of Imaging and Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Department of Cardiac Sciences, University of Calgary, Calgary, AB, Canada.

Donghee Han (D)

Departments of Imaging and Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

Alan Rozanski (A)

Division of Cardiology, Mount Sinai St. Luke's Hospital, Mount Sinai Heart, and the Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Heidi Gransar (H)

Departments of Imaging and Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

John D Friedman (JD)

Departments of Imaging and Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

Sean Hayes (S)

Departments of Imaging and Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

Louise Thomson (L)

Departments of Imaging and Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

Balaji Tamarappoo (B)

Departments of Imaging and Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

Piotr J Slomka (PJ)

Departments of Imaging and Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

Daniel S Berman (DS)

Departments of Imaging and Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA. bermand@cshs.org.
, Room 1258, 8700 Beverly Boulevard, Los Angeles, CA, 90048, USA. bermand@cshs.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH